Skip to content

Examination of the Impact of Better Surveillance and Communication of Patient Deterioration on Patient Related Outcomes

Examination of the Impact of Better Surveillance and Communication of Patient Deterioration on Patient Related Outcomes (VitalCare - Guardian Version 2)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01692847
Enrollment
678
Registered
2012-09-25
Start date
2012-10-31
Completion date
2016-02-29
Last updated
2016-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Respiratory Failure, Severe Sepsis

Keywords

patient deterioration, rapid response teams, acute care teams, early warning scoring

Brief summary

A hospitals manual method of patient monitoring will be implemented in an automated system and supported by an early patient deterioration detection for timely escalation. The purpose of this study is to assess if clinical outcomes of patients in Acute Care are significantly improved by such a system.

Detailed description

The purpose of this study is to assess if the Philips IntelliVue Guardian Solution (IGS) with all its components can significantly improve clinical outcomes for deteriorating patients on a general medical ward prior and after referral to the hospitals' Acute Care Team (ACT). Further, to provide evidence that the Philips IGS assists to increase the efficiency of a hospital's Early Warning Scoring process (afferent and efferent arm of the escalation system). The introduction of such an intelligent automated system offers a unique opportunity to address the breakdown in the chain of prevention by strengthening the reliability of calls-for-help to responders through a technical solution with the potential for a more timely escalation where appropriate. In this study the hospital's Standard of Care protocol for the monitoring of vital signs (including timing, vital signs collected and escalation instructions) will be implemented in a commercially available intelligent automatic monitoring and notification system. No investigational procedures or devices are associated with this protocol.

Interventions

None listed

Sponsors

Philips Healthcare
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* all patients admitted to the study units during the period of data collection

Exclusion criteria

* less than 24h on ward

Design outcomes

Primary

MeasureTime frameDescription
Improvement of outcome for patients after implementing the IGS15 monthsDoes the IGS significantly increase positive outcomes for deteriorating patients after referral to the RRT/ACT as measured by the MAELOR score

Secondary

MeasureTime frameDescription
Early detection of patient deterioration15 monthsDoes the IGS detect patient deterioration earlier and therefore prevent or shorten periods of severe illness.
Daily workload for the ward's personnel15 monthsDoes the IGS reduce the daily workload related to patient surveillance for the general ward personnel.
Level of satisfaction15 monthsDo Nurses and Doctors express a higher level of satisfaction with the IGS in place than with their current paper-based surveillance.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026